The Center for Advancement in Sports Medicine Innovation and Medical Devices
Project Description
According to relevant data statistics, in recent years, the growth rate of Sports Medicine has shown a significant upward trend in Orthopedics. It is expected that by 2027, the global Sports Medicine market will reach 15.2 billion RMB, with an estimated compound annual growth rate of 8.2%. Due to the increasing incidence of sports injuries and more people participating in sports, fitness, and other activities, there is a rising global demand for Sports Medicine. Currently, the segment of body reconstruction and repair dominates the Sports Medicine market, accounting for the largest revenue share at around 40%. The domestic market share of Sports Medicine in China is still relatively low, with imported products occupying the dominant position. Domestic enterprises are currently at the stage of active deployment. There exists a huge market, providing ample opportunities for domestic companies to replace imported ones. Simultaneously, the project optimizes products to truly make them user-friendly and cost-effective for patients.
This project innovatively applies degradable metals in the suture repair of meniscus. Due to the material properties of degradable metals, the mechanical performance far exceeds that of traditional polymer materials. This allows the product to meet the requirements of usage and fixation strength while minimizing the implant's volume and the dimensions of the stimulating device as much as possible, making the procedure more minimally invasive and causing less damage to the patient. Additionally, using degradable metals as implants allows them to completely degrade within a certain degradation period, resulting in no foreign body sensation in the body and no irritation to other soft tissues, leading to better postoperative outcomes. The used raw materials degrade into trace elements needed by the human body, posing no harm to the body and being absorbable by the body, effectively reducing clinical trauma and aiding in postoperative recovery.
Lead Arranger
Zheng Yufeng, Professor and Doctoral Supervisor of School of Materials Science and Engineering at Peking University, member of the National Special Support Program for High-Level Talents, “Fellow, Biomaterials Science and Engineering” (FBSE) of the International Union of Societies for Biomaterials Science and Engineering (IUSBSE), American Institute for Medical and Biological Engineering (AIMBE Fellow), and Fellow of the Chinese Society for Biomaterials. His academic research direction is New Biomedical Metal Materials and Devices. As the lead arranger, Zheng has undertaken government sponsored and commercial projects totaling 50+, including major programs of the 13th and 14th Five-Year Plan, the National Science Fund for Distinguished Young Scholars, the National Natural Science Foundation of China (NSFC), and the Joint Funds of NSFC. He has published two English monographs and six Chinese monographs, as well as more than 600 English papers in Science Citation Index (SCI), and have been cited over 40,500 times, with the H-Index of 100. He was recognized as one of the Clarivate Analytics Highly-cited Researchers 2022, and ranked 3218th on World’s Top 2% Scientists 2022, as well as 26802rd on Lifetime Scientific Influence Ranking, and has over 60 inventions with granted patents. His current part-time social work includes the Editor-in-Chief of Bioactive Materials, Editor of Materials Letters, Associate Editor-in-Chief of Journal of Materials Science& Technology, and Vice President of Chinese Society for Biomaterials.
